Share on StockTwits

RBC Life Sciences (NASDAQ:RBCL) CEO Clinton H. Howard purchased 5,000 shares of RBC Life Sciences stock on the open market in a transaction that occurred on Monday, June 16th. The stock was purchased at an average cost of $0.60 per share, with a total value of $3,000.00. Following the transaction, the chief executive officer now directly owns 982,860 shares in the company, valued at approximately $589,716. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

RBC Life Sciences (NASDAQ:RBCL) remained flat at $0.73 during during mid-day trading trading on Wednesday. The stock had a trading volume of 1,600 shares. RBC Life Sciences has a one year low of $0.01 and a one year high of $0.29. The stock’s 50-day moving average is $0.14 and its 200-day moving average is $0.14. The company’s market cap is $1.6 million.

RBC Life Sciences, Inc (NASDAQ:RBCL) is principally engaged in the marketing and distribution of nutritional supplements and personal care products (collectively Nutritional Products) through subsidiaries in the United States and Canada and, effective October 1, 2011, a branch office in Taiwan.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.